• HempFusion’s acquisition of Sagely Naturals opens the company to over 14,000 additional retail stores
• It marks a massive milestone following the $17 million TSX IPO in January 2020
• HempFusion looks to more than triple its 2020 revenue as this is part of the company’s expansion plan for 2021 and beyond 
• The move builds on HempFusion’s five-channel strategy while playing into Sagely Naturals’ opportunities and strengths

2021 is proving to be a good year for HempFusion Wellness (TSX: CBD.U) (OTCQX: CBDHF) (FWB: 8OO). In January, it completed its $17 million IPO to start trading on the Toronto Stock Exchange (“TSX”) (https://ibn.fm/8hTot). Fast forward to July; the company acquired Sagely Naturals in its most significant move yet as it works on a five-channel expansion strategy to conquer various markets, including the Middle East, China, India, Mexico, Europe, and South Korea (https://ibn.fm/cMnAc).

HempFusion’s acquisition of Sagely Naturals opens it to an additional 14,000 stores along with the latter’s retail distribution footprint. It also opens the company to product efficiencies across the topicals line while diversifying its overall product line that features its proprietary formulations.

Before Sagely Naturals’ acquisition, HempFusion offered 48 different products under a handful of brands, including Biome Research, HF Labs, Probulin Probiotics, and HempFusion (https://ibn.fm/QSoSq). They were sold in at least 4,000 retail locations in all 50 states within the United States through five main channels: e-commerce, natural health retailers, convenience stores, doctors/practitioners, and big-box/food and drug mass.

With Sagely Naturals in the picture, HempFusion now has access to the company’s robust distribution systems and infrastructure. Additionally, it has the opportunity to grow further its product line and, most importantly, leverage Sagely Naturals’ industry-leading marketing, advanced customer/channel relationships, and its proven innovation. Also, with Sagely Naturals’ acquisition, HempFusion looks to more than triple its 2020 revenue with its expansion plan for 2021 and beyond.

“We are incredibly excited to complete the acquisition of Sagely Naturals which provides HempFusion with a significant increase in revenue and immediate distribution to up to an additional 14,000 retail points nationally,” noted John Mitchell, the Chief Executive Officer (“CEO”) of HempFusion. “Integration has been underway over the past several weeks, and we look forward to driving shareholder value through continued growth in 2021 and 2022 both domestically and internationally with our expanding family of brands,” he added.

So far, HempFusion has successfully managed to win over big retailers with its hemp CBD products. Most notably, the company’s presence on Amazon has played a vital role in its success, brand recognition, and overall brand perception. With the Sagely Naturals’ acquisition, HempFusion plans on taking it a step further while also paying close attention to regulatory compliance procedures that will allow it to expand to other key markets across the world.

HempFusion’s focus over the past two and a half years has been on building a solid catalog for its products, ensuring all regulatory compliance guidelines are met and expanding its retail store footprint. With the CBD sector projected to get to $16.8 billion by 2025, the Sagely Naturals’ acquisition could not have come at a better time.

HempFusion is a leading health and wellness CBD company that utilizes the power of whole-food hemp nutrition. The company is committed to consistently meeting and exceeding the high standards required by retailers and consumers by prioritizing the quality and consistency of its products. The company is U.S. Hemp Authority Certified and even serves as a board member of the U.S. Hemp Roundtable, a coalition of leading companies committed to advancing safe hemp and CBD products.

Sagely Naturals’ acquisition marks a key milestone for HempFusion in its 2021 expansion plan. It builds on the company’s progress so far while laying down a solid foundation for its future expansion in terms of its product line and market reach. 

For more information, visit the company’s website at www.HempFusion.com/corporate-information.

NOTE TO INVESTORS: The latest news and updates relating to CBDHF are available in the company’s newsroom at https://ibn.fm/CBDHF

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.

With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.